Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.04) by 33.33 percent. This is a 25 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $1.279 million which missed the analyst consensus estimate of $1.900 million by 32.68 percent. This is a 46.17 percent increase over sales of $875.000 thousand the same period last year.